PLATFORM TECHNOLOGY
Immunomodulatory technology based on
human microbiome analysis.
Immune modulating technology through controlling microbiome.
- Screening of pharmabiotics sp. modulating intestinal dendritic cells
- Development of Bifidobacterium sp. activating T-regulatory cells
- Development of Bifidobacterium sp. activating T-effector cells
- Development of prebiotics promoting beneficial microbiome
Core Competitive
Technology
-
Strategic screening
of pharmabiotics -
Modulation of
microbiome -
Safety evaluation
-
Mass production of
strict anaerobes
Target indications
for pharmabiotics
Cancer immunotherapy
Rheumatoid arthritis
Sjogren's syndrome
